Inventor
KENNEDY ABIGAIL R
US16 patents
⚠️ This page may combine multiple inventors who share the name “KENNEDY ABIGAIL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXELIXIS INC
9 patentsUS7704995B2Apr 27, 2010
Protein kinase modulators and methods of use
EXELIXIS INC64 citations96
US7803839B2Sep 28, 2010
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC46 citations95
US8372851B2Feb 12, 2013
Pyrazolo pyrimidines as casein kinase II (CK2) modulators
EXELIXIS INC20 citations91
US7915250B2Mar 29, 2011
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC22 citations91
US8362002B2Jan 29, 2013
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC12 citations83
US7872014B2Jan 18, 2011
Anaplastic lymphoma kinase modulators and methods of use
EXELIXIS INC7 citations70
US11597699B2Mar 7, 2023
MEK inhibitors and methods of their use
EXELIXIS INC0 citations61
US7846959B2Dec 7, 2010
Raf modulators and methods of use
EXELIXIS INC3 citations60
US8012956B2Sep 6, 2011
Tropane compounds
EXELIXIS INC1 citations50
RICE KENNETH D
3 patentsUS7576074B2Aug 18, 2009
Receptor-type kinase modulators and methods of use
RICE KENNETH D21 citations90
US8658654B2Feb 25, 2014
Receptor-type kinase modulators and methods of use
RICE KENNETH D3 citations60
US8101625B2Jan 24, 2012
Pyrimidinones as Casein Kinase II (CK2) modulators
RICE KENNETH D2 citations59
SYMPHONY EVOLUTION INC
3 patentsUS10266518B2Apr 23, 2019
Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
SYMPHONY EVOLUTION INC0 citations51
US9796704B2Oct 24, 2017
Substituted quinazolines as receptor-type kinase inhibitors
SYMPHONY EVOLUTION INC0 citations51
US9359332B2Jun 7, 2016
Processes for the preparation of substituted quinazolines
SYMPHONY EVOLUTION INC0 citations51